RU94031102A - Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний - Google Patents
Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеванийInfo
- Publication number
- RU94031102A RU94031102A RU94031102/04A RU94031102A RU94031102A RU 94031102 A RU94031102 A RU 94031102A RU 94031102/04 A RU94031102/04 A RU 94031102/04A RU 94031102 A RU94031102 A RU 94031102A RU 94031102 A RU94031102 A RU 94031102A
- Authority
- RU
- Russia
- Prior art keywords
- endotheelin
- sulfides
- antagonists
- corresponding diseases
- treating corresponding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Соединения формулы, приведенной в описании, в которой R является фенилом, нафтилом или дифенилилом, каждый из которых может быть замещен, ингибируют эндотелин.
Claims (1)
- Соединения формулы, приведенной в описании, в которой R является фенилом, нафтилом или дифенилилом, каждый из которых может быть замещен, ингибируют эндотелин.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US114,251 | 1993-08-30 | ||
US08/114,251 US5965732A (en) | 1993-08-30 | 1993-08-30 | Sulfonamide endothelin antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94031102A true RU94031102A (ru) | 1996-07-10 |
RU2141953C1 RU2141953C1 (ru) | 1999-11-27 |
Family
ID=22354178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94031102/04A RU2141953C1 (ru) | 1993-08-30 | 1994-08-29 | Сульфамидные соединения или их фармацевтически пригодные соли и способ ингибирования рецепторов ета |
Country Status (17)
Country | Link |
---|---|
US (1) | US5965732A (ru) |
EP (1) | EP0640596A1 (ru) |
JP (1) | JPH07109263A (ru) |
KR (1) | KR950005811A (ru) |
CN (1) | CN1057295C (ru) |
AU (1) | AU680522B2 (ru) |
CA (1) | CA2130971A1 (ru) |
CZ (1) | CZ288478B6 (ru) |
FI (1) | FI943926A (ru) |
HU (1) | HUT68421A (ru) |
IL (1) | IL110743A (ru) |
NO (1) | NO305317B1 (ru) |
NZ (1) | NZ264319A (ru) |
PL (1) | PL175927B1 (ru) |
RU (1) | RU2141953C1 (ru) |
TW (1) | TW411334B (ru) |
ZA (1) | ZA946571B (ru) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5594021A (en) * | 1993-05-20 | 1997-01-14 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5571821A (en) * | 1993-05-20 | 1996-11-05 | Texas Biotechnology Corporation | Sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5464853A (en) * | 1993-05-20 | 1995-11-07 | Immunopharmaceutics, Inc. | N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
US5591761A (en) * | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5514691A (en) * | 1993-05-20 | 1996-05-07 | Immunopharmaceutics, Inc. | N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5514696A (en) * | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
US6342610B2 (en) | 1993-05-20 | 2002-01-29 | Texas Biotechnology Corp. | N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US6030991A (en) * | 1993-05-20 | 2000-02-29 | Texas Biotechnology Corp. | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
GB9504854D0 (en) * | 1994-03-31 | 1995-04-26 | Zeneca Ltd | Nitrogen derivatives |
GB9409618D0 (en) * | 1994-05-13 | 1994-07-06 | Zeneca Ltd | Pyridine derivatives |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
US5760038A (en) * | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5780473A (en) * | 1995-02-06 | 1998-07-14 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
UA58494C2 (ru) * | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Производные n-гетероарилпиридинсульфонамида, фармацевтическая композиция, способ получения и способ противодействия влияниям эндотелина |
GB9512697D0 (en) * | 1995-06-22 | 1995-08-23 | Zeneca Ltd | Heterocyclic compounds |
US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
US6573282B1 (en) | 1995-09-12 | 2003-06-03 | Adolor Corporation | Peripherally active anti-hyperalgesic opiates |
US5849761A (en) | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
JPH09124620A (ja) | 1995-10-11 | 1997-05-13 | Bristol Myers Squibb Co | 置換ビフェニルスルホンアミドエンドセリン拮抗剤 |
US5977117A (en) | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
US5856507A (en) * | 1997-01-21 | 1999-01-05 | Bristol-Myers Squibb Co. | Methods for the preparation of biphenyl isoxazole sulfonamides |
HUP0002351A3 (en) | 1996-02-20 | 2001-10-29 | Bristol Myers Squibb Co | Methods for the preparation of biphenyl isoxazole sulfonamides, intermediates and process for preparing them |
US5958905A (en) | 1996-03-26 | 1999-09-28 | Texas Biotechnology Corporation | Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
US5939446A (en) * | 1996-04-09 | 1999-08-17 | Bristol-Myers Squibb Co. | Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists |
US5804585A (en) * | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
AU6187898A (en) * | 1997-01-30 | 1998-08-25 | Bristol-Myers Squibb Company | Method for preventing or treating low renin hypertension by administering an endothelin antagonist |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
CA2496680A1 (en) | 1997-04-28 | 1998-11-05 | Encysive Pharmaceuticals Inc. | Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
US5783705A (en) | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
US6638937B2 (en) | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
MXPA01009362A (es) | 1999-03-19 | 2002-06-04 | Squibb Bristol Myers Co | Metodos para la preparacion de bifenil isoxazol sulfonamidas. |
US6639082B2 (en) | 2000-10-17 | 2003-10-28 | Bristol-Myers Squibb Company | Methods for the preparation of biphenyl isoxazole sulfonamides |
KR20030061051A (ko) * | 2002-01-07 | 2003-07-18 | 대한민국 (경상대학교 총장) | 신규한 아렌(혹은 알케인)술폰일피리다진온 유도체, 이의제조방법 및 유기반응에서의 용도 |
GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
AU2007225139A1 (en) * | 2006-03-13 | 2007-09-20 | Encysive Pharmaceuticals, Inc. | Methods and compositions for treatment of diastolic heart failure |
CA2644784A1 (en) * | 2006-03-13 | 2007-09-20 | Jinling Chen | Formulations of sitaxsentan sodium |
US20080026061A1 (en) * | 2006-06-22 | 2008-01-31 | Reichwein John F | Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide |
CN101812063B (zh) * | 2010-03-18 | 2012-04-25 | 中国医学科学院医药生物技术研究所 | α-萘磺酰胺基五元杂环类化合物及其抑瘤活性 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2524802A (en) * | 1949-01-07 | 1950-10-10 | American Cyanamid Co | Hydroxybenzenesulfonamidopyridazines and preparation of same |
US2542856A (en) * | 1949-06-24 | 1951-02-20 | American Cyanamid Co | N-thiadiazolyl-4-iodobenzenesulfonamides |
GB804036A (en) * | 1956-03-02 | 1958-11-05 | Hoffmann La Roche | A process for the manufacture of a sulphanilamide of the isoxazole series |
US2888455A (en) * | 1956-09-04 | 1959-05-26 | Shionogi & Co | New sulfonamide and process for producing the same |
US3055886A (en) * | 1960-02-12 | 1962-09-25 | American Cyanamid Co | Process for condensation of sulfanilamide with halodiazines |
GB1473433A (ru) * | 1975-10-09 | 1977-05-11 | Banyu Pharmaceutical Co Ltd Hi | |
US4415496A (en) * | 1981-03-23 | 1983-11-15 | Merck & Co., Inc. | Bicyclic lactams |
DE3276313D1 (en) * | 1981-09-24 | 1987-06-19 | Beecham Wuelfing Gmbh & Co Kg | Sulphonamides |
US4661479A (en) * | 1982-02-19 | 1987-04-28 | Merck And Co., Inc. | Bicyclic lactams as antihypertensives |
EP0194548A3 (de) * | 1985-03-12 | 1988-08-17 | Dr. Karl Thomae GmbH | Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US5571821A (en) * | 1993-05-20 | 1996-11-05 | Texas Biotechnology Corporation | Sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5514691A (en) * | 1993-05-20 | 1996-05-07 | Immunopharmaceutics, Inc. | N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5464853A (en) * | 1993-05-20 | 1995-11-07 | Immunopharmaceutics, Inc. | N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
CA2005741C (en) * | 1988-12-26 | 1998-06-02 | Hiroyoshi Hidaka | Quinoline sulfonoamino compounds having vessel smooth muscle relaxation activity |
US5082838A (en) * | 1989-06-21 | 1992-01-21 | Takeda Chemical Industries, Ltd. | Sulfur-containing fused pyrimidine derivatives, their production and use |
DE19675036I2 (de) * | 1990-02-19 | 2004-10-21 | Novartis Ag | Acylverbindungen. |
TW270116B (ru) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
PL176250B1 (pl) * | 1991-11-05 | 1999-05-31 | Smithkline Beecham Corp | Sposób wytwarzania pochodnych indanu |
SE9103397D0 (sv) * | 1991-11-18 | 1991-11-18 | Kabi Pharmacia Ab | Nya substituerade salicylsyror |
TW224462B (ru) * | 1992-02-24 | 1994-06-01 | Squibb & Sons Inc | |
NZ247440A (en) * | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
US5514696A (en) * | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
GB9504854D0 (en) * | 1994-03-31 | 1995-04-26 | Zeneca Ltd | Nitrogen derivatives |
-
1993
- 1993-08-30 US US08/114,251 patent/US5965732A/en not_active Expired - Lifetime
-
1994
- 1994-08-11 CZ CZ19941948A patent/CZ288478B6/cs not_active IP Right Cessation
- 1994-08-22 IL IL11074394A patent/IL110743A/en not_active IP Right Cessation
- 1994-08-25 EP EP94306273A patent/EP0640596A1/en not_active Ceased
- 1994-08-26 FI FI943926A patent/FI943926A/fi unknown
- 1994-08-26 JP JP6201876A patent/JPH07109263A/ja active Pending
- 1994-08-26 NZ NZ264319A patent/NZ264319A/en unknown
- 1994-08-26 AU AU71471/94A patent/AU680522B2/en not_active Ceased
- 1994-08-26 TW TW083107856A patent/TW411334B/zh not_active IP Right Cessation
- 1994-08-26 CA CA002130971A patent/CA2130971A1/en not_active Abandoned
- 1994-08-29 ZA ZA946571A patent/ZA946571B/xx unknown
- 1994-08-29 RU RU94031102/04A patent/RU2141953C1/ru not_active IP Right Cessation
- 1994-08-29 PL PL94304822A patent/PL175927B1/pl unknown
- 1994-08-29 HU HU9402486A patent/HUT68421A/hu unknown
- 1994-08-29 NO NO943190A patent/NO305317B1/no not_active IP Right Cessation
- 1994-08-29 KR KR1019940021352A patent/KR950005811A/ko active IP Right Grant
- 1994-08-30 CN CN94115609A patent/CN1057295C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HUT68421A (en) | 1995-06-28 |
PL175927B1 (pl) | 1999-03-31 |
HU9402486D0 (en) | 1994-10-28 |
CZ194894A3 (en) | 1995-10-18 |
IL110743A (en) | 1998-10-30 |
FI943926A0 (fi) | 1994-08-26 |
FI943926A (fi) | 1995-03-01 |
AU7147194A (en) | 1995-03-09 |
RU2141953C1 (ru) | 1999-11-27 |
ZA946571B (en) | 1995-03-22 |
KR950005811A (ko) | 1995-03-20 |
TW411334B (en) | 2000-11-11 |
NZ264319A (en) | 1996-02-27 |
US5965732A (en) | 1999-10-12 |
IL110743A0 (en) | 1994-11-11 |
CN1057295C (zh) | 2000-10-11 |
EP0640596A1 (en) | 1995-03-01 |
NO305317B1 (no) | 1999-05-10 |
NO943190L (no) | 1995-03-01 |
AU680522B2 (en) | 1997-07-31 |
PL304822A1 (en) | 1995-03-06 |
CA2130971A1 (en) | 1995-03-01 |
CZ288478B6 (en) | 2001-06-13 |
CN1106805A (zh) | 1995-08-16 |
NO943190D0 (no) | 1994-08-29 |
JPH07109263A (ja) | 1995-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94031102A (ru) | Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний | |
ATE224374T1 (de) | 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen | |
RU94041950A (ru) | Использование соединений ряда 3-аролоксипропиламинов в лечении недержания | |
ATE250576T1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
NO996269L (no) | Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
DE59409832D1 (de) | Pflaster zur behandlung von nagelmykosen | |
DE69508192T2 (de) | Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen | |
DE10075033I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur Behandlung von Entzuendungen | |
FI952607A (fi) | Farmakologisesti aktiiviset pyridiinijohdannaiset ja menetelmät niiden valmistamiseksi | |
ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
FI971951A0 (fi) | 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon | |
ES8800160A1 (es) | Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales. | |
DE69617005D1 (de) | 2-amino-benzoxazinone zur behandlung von viralen infektionen | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
BR9408244A (pt) | Derivados de azabiciclo[3.2.0]heptano N-substituídos | |
DE69307674T2 (de) | HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS | |
ATE209914T1 (de) | Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen | |
ATE328898T1 (de) | Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung | |
ES2094545T3 (es) | Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc.. | |
AU1192397A (en) | Substituted thiazolines and their use for controlling animal pests | |
NO991734L (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
DE68926222D1 (de) | Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20020830 |